The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 7
- 0 vs. Q4 2021
- Portfolio value
- $539.4M
- −$195.9M (−26.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 16,245,817 | $247.7M | 45.9% | +849,701+5.5% | Added | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $110.7M | 20.5% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,347,245 | $85.4M | 15.8% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,402,008 | $30.8M | 5.7% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,414,795 | $28.3M | 5.3% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $19.1M | 3.5% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $17.3M | 3.2% | 00.0% | Unchanged | History |